Cediranib, Olaparib clinical trials

A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer

This study looks at new drug combinations (Cediranib and Olaparib) for women with advanced cervical cancer that has come back. It aims to see if these drugs can stop the cancer from growing for longer after their initial chemotherapy treatment.